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Research
The association of ambient particulate matter 
(PM) exposures with mortality and cardio­
vascular outcomes has been well established 
in studies of short­term exposure (Committee 
on the Medical Effects of Air Pollutants 
2006; Levy et al. 2000; Samet et al. 2000a, 
2000b; Zanobetti et al. 2000). The literature 
on health outcomes associated with long­term 
PM exposures has been growing. Beginning 
with the Harvard Six Cities Study and the 
American Cancer Society Study, research­
ers have reported increased risks of all­cause 
and cardiopulmonary mortality with chronic 
exposures (Dockery et al. 1993; Pope et al. 
1995). More recent cohort studies have con­
firmed these findings (Brunekreef et al. 2009; 
Eftim et al. 2008; Laden et al. 2006; Miller 
et al. 2007; Pope et al. 2004; Puett et al. 
2008, 2009).
A few recently published cohort studies 
have focused on women and have reported 
stronger effect estimates for fatal coronary 
heart disease (CHD) and all­cause mortal­
ity than previous studies (Miller et al. 2007; 
Puett et al. 2008, 2009).
Questions remain regarding sex dif­
ferences in the associations of chronic PM 
exposures with all­cause and cardiovascular 
mortality. In the present study we applied the 
same spatiotemporal exposure modeling used 
in the all­female Nurses’ Health Study cohort 
to examine similar relationships among the 
all­male Health Professionals Follow­Up 
Study cohort.
Materials and Methods
Study population. The Health Professionals 
Follow­Up Study cohort consists of 51,529 
male dentists, pharmacists, optometrists, 
podiatrists, osteopaths, and veterinarians 
residing in the United States. The cohort 
began with a baseline questionnaire in 1986, 
when participants were 40–75 years of age. 
The Health Professionals Follow­Up Study 
was approved by the Harvard School of 
Public Health Institutional Review Board, 
and returning the completed questionnaires 
constituted implied consent to use the data in 
ongoing research. Follow­up questionnaires 
are mailed every 2 years, with response rates 
of approximately 93%. The current study is 
limited to participants living in 13 contiguous 
northeastern and midwestern states (Maine, 
Vermont, New Hampshire, Massachusetts, 
Rhode Island, Connecticut, New York, 
New Jersey, Delaware, Pennsylvania, Ohio, 
Michigan, and Maryland) for comparison 
with our recent studies in the Nurses’ Health 
Study. Health professionals were excluded 
for any time period during which they lived 
outside this region.
Outcomes. The outcomes for the current 
study were all­cause mortality (excluding acci­
dental deaths), nonfatal myocardial infarction 
(MI), fatal CHD, and hemorrhagic and isch­
emic stroke. We also examined total cardio­
vascular disease (CVD) events including fatal 
CHD, nonfatal MI, and total strokes. Deaths 
were confirmed by families, postal officials, 
and the National Death Index. We included 
MIs if medical record information met World 
Health Organization criteria (presence of 
symptoms and typical electrocardiographic 
changes or elevated cardiac enzyme levels) or 
if the patient was hospitalized and additional 
corroborating correspondence was obtained 
confirming the diagnosis (Rose and Blackburn 
1982). Men with MIs before baseline were 
excluded. Fatal CHD was confirmed through 
hospital records or by a death certificate list­
ing CHD as the primary cause or the most 
plausible cause and previous history of the 
disease were available. Strokes were included 
if medical records showed evidence of typical 
neurologic deficit of sudden or rapid onset 
lasting ≥ 24 hr attributed to a cerebrovascu­
lar event or if the participant was hospital­
ized and the supplementary correspondence 
corroborated the diagnosis. Hemorrhagic 
and ischemic strokes were categorized using 
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Ba c k g r o u n d: The association of all-cause mortality and cardiovascular outcomes with air   pollution 
exposures has been well established in the literature. The number of studies examining chronic 
exposures in cohorts is growing, with more recent studies conducted among women finding risk 
estimates of greater magnitude. Questions remain regarding sex differences in the relationship of 
chronic particulate matter (PM) exposures with mortality and cardiovascular outcomes.
oBjectives: In this study we explored these associations in the all-male Health Professionals 
Follow-Up Study prospective cohort.
Me t h o d s : The same spatiotemporal exposure estimation models, similar outcomes, and biennially 
updated covariates were used as those previously applied in the female Nurses’ Health Study cohort.
re s u l t s: Among 17,545 men residing in the northeastern and midwestern United States, there 
were 2,813 deaths, including 746 cases of fatal coronary heart disease (CHD). An interquartile 
range change (4 µg/m3) in average exposure to PM ≤ 2.5 µm in diameter in the 12 previous months 
was not associated with all-cause mortality [hazard ratio (HR) = 0.94; 95% confidence interval (CI), 
0.87–1.00] or fatal CHD (HR = 0.99; 95% CI, 0.87–1.13) in fully adjusted models. Findings were 
similar for separate models of exposure to PM ≤ 10 µm in diameter and PM between 2.5 and 10 µm 
in diameter and for copollutant models.
co n c l u s i o n s: Among this cohort of men with high socioeconomic status living in the midwestern 
and northeastern United States, the results did not support an association of chronic PM expo-
sures with all-cause mortality and cardiovascular outcomes in models with time-varying covariates. 
Whether these findings suggest sex differences in susceptibility or the protective impact of healthier 
lifestyles and higher socioeconomic status requires additional investigation.
key w o r d s : air pollution, cardiovascular disease, mortality, particulate matter. Environ Health 
Perspect 119:1130–1135 (2011).  doi:10.1289/ehp.1002921 [Online 31 March 2011]Chronic PM, CVD, and mortality in the HPFS
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National Survey of Stroke criteria (Walker 
et al. 1981). Men who experienced strokes 
before baseline were excluded. All medical 
records were reviewed by physicians blinded 
to exposure status of the participants.
Exposure assessment. Spatiotemporal models 
were developed to estimate monthly exposures 
to PM ≤ 2.5 µm in diameter (PM2.5) and PM 
≤ 10 µm in diameter (PM10) for each address 
of each participant. Exposures to PM between 
2.5 and 10 µm in diameter (PM10–2.5) were 
estimated for each month and location by sub­
tracting the PM2.5 modeled estimates from the 
PM10 modeled estimates. These models allowed 
us to predict chronic PM exposure levels for 
all individuals with a geocoded address, even 
those living in areas with no nearby monitors. 
The models are described in detail elsewhere 
(Paciorek et al. 2009a; Yanosky et al. 2008, 
2009). Briefly, the models use a geographic 
information system (GIS)­based spatial smooth­
ing model and include pollution data from 
monitoring sites in the U.S. Environmental 
Protection Agency Air Quality System (AQS) 
(U.S. Environmental Protection Agency 
2009), the Visibility Information Exchange 
Web System (VIEWS 2004), the Interagency 
Monitoring of Protected Visual Environments 
(IMPROVE) network, Stacked Filter Unit (a 
predecessor to IMPROVE), Clean Air Status 
and Trends (CASTNet) networks (Paciorek 
et al. 2009a, 2009b; Yanosky et al. 2008, 
2009), and Harvard research studies (Spengler 
et al. 1996; Suh et al. 1997), as well as GIS­
derived covariates including population den­
sity, distance to nearest road, elevation, urban 
land use, point­source and area­source primary 
emissions, and meteorological information. 
To allow for sparse PM2.5 monitoring before 
1999, in previous studies separate generalized 
additive mixed models were constructed for 
the time periods from 1988 to 1998 and from 
1999 to 2002 (Paciorek et al. 2009a; Yanosky 
et al. 2008, 2009). To compensate for the rela­
tive lack of PM2.5 data, the pre­1999 model 
added extinction coefficients and a simpler spa­
tiotemporal structure to estimate the PM2.5 
to PM10 ratio seasonally. Point­source PM2.5 
emissions were included in the post­1999 
PM2.5 model. The models were evaluated using 
cross­validation; they exhibited little bias and 
high precision (Paciorek et al. 2009a; Yanosky 
et al. 2008, 2009).
Evaluation of confounders and effect modi-
fiers. Questionnaires were originally mailed in 
January 1986, and follow­up questionnaires 
were sent in January of sub  sequent even­
numbered years. Data from these   biennial 
questionnaires were used to assess poten­
tial confounding and effect modification by 
  covariates. We selected covariates a priori 
based on known risk factors for mortality and 
CVD in the general population and specific 
to this cohort (Chiuve et al. 2008; Cho et al. 
2002; Pischon et al. 2005). We examined con­
founding by adjustment and effect modifica­
tion through the use of interaction terms and 
stratification for hypertension (yes, no), hyper­
cholesterolemia (yes, no), diabetes mellitus 
(yes, no), physical activity [< 3; 3 to < 9; 9 to 
< 18; 18 to < 27; or ≥ 27 metabolic equiva­
lents (MET)hr/week], alcohol consumption 
(0; 0.1–4.9; 5.0–14.9; ≥ 15 g/day), body mass 
index (BMI, continuous), smoking status 
(never, former, or current), smoking pack­
years, and low­ versus high­risk diet. A low­
risk diet was assessed as a diet with a high ratio 
of polyunsaturated to saturated fat, high in 
cereal fiber, and low in trans fat and glycemic 
load (details described elsewhere) (Hu et al. 
2001). Family history of MI was examined 
on the baseline questionnaire. On the baseline 
questionnaire, information was also available 
to determine if the mailing address provided 
was a residential or business location.
Statistical analysis. We used time­varying 
Cox proportional hazards models to assess the 
relationships of all­cause mortality and car­
diovascular outcomes with predicted PM10, 
PM2.5, and PM10–2.5 exposures averaged over 
the 12 months before each outcome. All sur­
vival models were based on a monthly time 
scale and were used to estimate hazard ratios 
(HRs) and 95% confidence intervals (CIs). 
Person­years of follow­up time were calculated 
from baseline (January 1989) until the end of 
follow­up (January 2003). Person­time spent 
living outside the geographic region of interest 
was excluded, as were men with cardiovascu­
lar outcomes before baseline. Incidence rates 
were estimated as the number of new cases 
divided by person­years of follow­up. Each 
particulate size fraction was assessed in sepa­
rate and combined models. Cox models were 
stratified by age in months to control finely 
for age in a nonparametric way. Models were 
also adjusted for year (linear term), season 
(indicator variables), and for state of residence 
(indicator variables), rather than stratifying by 
these covariates, to maximize the number of 
cases in strata. Effect modification was assessed 
through the use of interaction terms in the 
models, as well as through likelihood ratio 
tests (LRT). In a sensitivity analysis, we com­
pared model results for each size fraction of 
PM for additional time windows of exposure: 
24, 36, and 48 months. We also conducted 
sensitivity analyses excluding participants who 
resided outside metropolitan statistical areas 
(MSAs). All statistical analyses used SAS ver­
sion 9.2 (SAS Institute Inc., Cary, NC).
Results
A total of 17,545 men were included at 
baseline, with a mean age of approximately 
57 years (Table 1). Most were never or for­
mer smokers at baseline, with current smok­
ers decreasing to about 5% of the study 
population by the end of follow­up. The per­
centages of men who reported hypertension, 
hyper  cholesterolemia, or diabetes increased 
considerably from baseline (26.5, 24.3, and 
4.3%, respectively) to the end of follow­up 
(47.5, 56.6, and 9.8%, respectively). About 
33% of the men reported ≥ 27 MET hr/week 
of physical activity in 1989, with the per­
cent of respondents in this category growing 
by the end of follow­up. About 23% of the 
study population lived in New York, with 
15% in Pennsylvania, 14% in Michigan, 
13% in Ohio, and 10% in New Jersey. At 
the beginning of the study, the average annual 
estimated exposure was 27.9 µg/m3 for PM10, 
17.8 µg/m3 for PM2.5, and 10.1 µg/m3 
for PM10–2.5. In general, annual predicted 
PM exposures decreased over the follow­up 
period, with PM10 showing the largest decline 
(Figure 1). We performed correlations among 
various time windows of average exposure 
(12, 24, 36, and 48 months) for each PM 
fraction. All time windows were highly cor­
related (ρ > 0.86).
There were 2,813 deaths, 746 cases of 
fatal CHD, 646 cases of nonfatal MI, 1,661 
cases of total CVD, 230 ischemic strokes, and 
Table 1. Characteristics for the Health Professionals 
Follow-Up Study at baseline for the current study 
in 1989.
Variable Value
n 17,545
Age (years) 57.4 ± 9.8
BMI 25.8 ± 3.4
Smoking status (%)
Never 44.9
Current 9.5
Former 45.5
No. of pack-years 25.2 ± 19.4
Hypertension (%) 26.5
Hypercholesterolemia (%) 24.3
Diabetes (%) 4.3
Family history of MI (%) 14.0
Low-risk diet (%) 42.5
Alcohol consumption [g/day (%)]
0 20.8
0.1–4.9 27.5
5.0–14.9 28.1
≥ 15.0 23.6
Physical activity [hr/week (%)]
< 3 MET 14.9
3 to < 9 19.1
9 to < 18 19.0
18 to < 27 13.8
≥ 27 33.2
Predicted PM10 (µg/m3)
Mean ± SD 27.9 ± 5.8
Interquartile range 7.4
Predicted PM2.5 (µg/m3)
Mean ± SD  17.8 ± 3.4
Interquartile range 4.3
Predicted PM10–2.5 (µg/m3)
Mean ± SD  10.1 ± 3.3
Interquartile range 4.3
Values are mean ± SD or percent unless otherwise 
noted. Percentages are based on complete data for 
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70 hemorrhagic strokes (Table 2). An inter­
quartile range (4 µg/m3) change in average 
PM2.5 exposure in the 12 previous months 
was not associated with all­cause mortality 
(HR = 0.96; 95% CI, 0.90–1.03) or ischemic 
strokes (HR = 0.84; 95% CI, 0.67–1.06) in 
basic models adjusting for time and state of 
residence and stratified by age. The HR for 
fatal CHD was 1.01 (95% CI, 0.89–1.15), 
1.02 for total CVD (95% CI, 0.94–1.11), and 
1.06 for nonfatal MI (95% CI, 0.92–1.22) in 
similar models. For comparison purposes with 
other studies, translating these relative risks 
(RRs) to a 10­µg/m3 unit change in PM2.5 
exposure results in an HR for all­cause mortal­
ity of 0.90 (95% CI, 0.76–1.06), HR for fatal 
CHD of 1.02 (95% CI, 0.74–1.41), and HR 
for total CVD of 1.05 (95% CI, 0.85–1.30). 
The HR for an interquartile range change 
in average PM2.5 exposure hemorrhagic 
strokes was highest, but the number of cases 
was small (HR = 1.14; 95% CI, 0.79–1.65). 
The HRs were very simi  lar in fully adjusted 
models with additional adjustment for BMI, 
hypertension, hypercholesterolemia, diabetes, 
family history of MI, smoking (status and 
pack­years), physical activity, healthy diet, 
and alcohol consumption. For example, the 
fully adjusted HR for total CVD was 1.01 
(95% CI, 0.93–1.10). Results were similar 
for interquartile range increases in PM10 
(7 µg/m3) and PM10–2.5 (4 µg/m3) separately, 
as well as in copollutant models with PM2.5 
and PM10–2.5 (Table 3).
Effect modification was evident for PM2.5 
associations (Table 4). Men without a family 
history of MI were at significantly lower risk 
for all­cause mortality associated with an inter­
quartile range increase in chronic fine particu­
late exposure compared with men with such a 
history. Analysis of PM2.5 exposures and fatal 
CHD stratified by smoking status show an 
increased risk for fatal CHD associated with 
chronic fine particulate exposure among never 
smokers. Although the HR for current smokers 
was higher than that estimated for never smok­
ers, there was only a small number of current 
smokers with fatal CHD, and there was no 
apparent relationship for former smokers.
Sensitivity analyses showed that model 
results were stable using different time win­
dows of average exposure for each size fraction 
of PM, as well as excluding state of residence 
from the final models. Findings also did not 
change when participants residing outside of 
MSAs were excluded or when the addresses 
used for exposure assessment were limited to 
those we were able to confirm as residential 
(data not shown). Finally, we conducted sen­
sitivity analyses excluding men with prior can­
cers (other than nonmelanoma skin cancer) as 
well as including men with prior stroke and 
CHD, and these results were also comparable 
(data not shown).
Discussion
Among men participating in the Health 
Professionals Follow­up Study cohort living 
in the northeastern and midwestern United 
States, we found no evidence of an associa­
tion between all­cause mortality and an inter­
quartile­range increase in estimated exposure 
to PM2.5 , PM10–2.5, or PM10 averaged over 
the prior 12 months. We observed similar 
results for total CVD and fatal CHD with all 
size fractions of particulate exposures and with 
PM2.5 and PM10 for ischemic strokes. Risk of 
ischemic stroke and risk of nonfatal MI were 
slightly elevated with increases in PM10–2.5 
and with all sizes of particulate exposures, 
respectively.
In contrast to other cohort studies of 
chronic exposures among men and women 
combined, the present study showed essentially 
no association. Both the original and extended 
follow­up of the Harvard Six Cities Study 
found all­cause and cardiopulmonary mor­
tality significantly associated with long­term 
exposures to PM2.5, with increased risks for 
all­cause mortality ranging from 13 to 16% 
and cardiopulmonary risks from 18 to 28% 
for each 10­µg/m3 increase in PM2.5 (Dockery 
et al. 1993; Laden et al. 2006). The original 
and extended American Cancer Society Study 
included data collected as part of the nation­
wide Cancer Prevention Study II, restricting 
the approximately 1.2 million participants to 
those living in metropolitan areas with avail­
able pollution data. Reported risks associated 
with PM2.5 were lower than those from the 
Harvard Six Cities Study but still statistically 
significant (ranging from 4 to 6% for all­cause 
and from 6 to 9% for cardiopulmonary mor­
tality per 10­µg/m3 increase in PM2.5) (Pope 
et al. 1995, 2002). A recent reanalysis of the 
American Cancer Society Study exploring 
adjustment for ecologic covariates also found 
an increase when adjusting for median house­
hold income (per 10­µg/m3 increase in PM2.5 
RR for all­cause mortality: 1.05; 95% CI, 
1.03–1.07) compared with no adjustment for 
ecologic covariates (RR for PM2.5: 1.03; 95% 
CI, 1.02–1.05) (Krewski et al. 2009). In the 
Medicare Cohort Air Pollution Study, Zeger 
et al. (2008) examined the relationship of all­
cause mortality with a 6­year average expo­
sure to fine particulates in ZIP code regions of 
the eastern region of the United States, which 
encompassed the geographic area of our study. 
The risk associated with a 10­µg/m3 increase 
in PM2.5 exposure was 6.8% (95% CI, 
4.9–8.7%), adjusting for socioeconomic status 
(education, poverty, unemployment, income) 
and chronic obstructive pulmonary disease. 
Results were stronger for the central United 
States (13.2; 95% CI, 9.5–16.9) and lower for 
the western United States (–1.1; 95% CI, –3.0 
to 0.8). Results from the Netherlands Cohort 
Study (NCLS) of men and women were simi­
lar to American Cancer Society Study findings 
(Brunekreef et al. 2009). The risk of CVD 
mortality was 1.04 (95% CI, 0.90–1.21) with 
a 10­µg/m3 increase in PM2.5. However, the 
same risk for an embedded case­cohort study 
was 0.83 (95% CI, 0.60–1.15), adjusting for 
a much larger number of potential confound­
ers. Finally, similar to our findings, a study 
of male veterans (Lipfert et al. 2006) did not 
find evidence of an association between PM2.5 
(mean ± SD, 14.3 ± 3.0 µg/m3) and all­cause 
Figure 1. Mean annual estimated PM exposures 
from 1988 to 2002 in the northeastern and mid-
western United States.
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Table 2. HRs (95% CIs) for associations of an interquartile-range change in average predicted PM exposure, adjusting for covariates.
PM2.5 (IQR = 4 µg/m3) PM10 (IQR = 7 µg/m3) PM10–2.5 (IQR = 4 µg/m3)
Outcome Cases Person-years Basic modela Full modelb Basic modela Full modelb Basic modela Full modelb
All-cause mortality 2,813 220,552 0.96 (0.90–1.03) 0.94 (0.87–1.00) 0.97 (0.91–1.03) 0.94 (0.89–1.00) 0.98 (0.93–1.04) 0.96 (0.91–1.02)
Fatal CHD 746 220,562 1.01 (0.89–1.15) 0.99 (0.87–1.13) 1.04 (0.93–1.16) 1.01 (0.90–1.14) 1.05 (0.94–1.16) 1.02 (0.92–1.14)
Nonfatal MI 646 214,919 1.06 (0.92–1.22) 1.06 (0.92–1.22) 1.05 (0.92–1.18) 1.04 (0.92–1.18) 1.03 (0.92–1.15) 1.02 (0.91–1.15)
Total CVD 1,661 212,649 1.02 (0.94–1.11) 1.01 (0.93–1.10) 1.04 (0.96–1.12) 1.02 (0.95–1.10) 1.04 (0.97–1.11) 1.03 (0.96–1.11)
Ischemic strokes 230 218,944 0.84 (0.67–1.06) 0.86 (0.68–1.08) 0.97 (0.79–1.19) 0.98 (0.80–1.21) 1.08 (0.90–1.29) 1.08 (0.90–1.30)
Hemorrhagic strokes 70 220,292 1.14 (0.79–1.65) 1.17 (0.81–1.69) 0.99 (0.70–1.41) 1.01 (0.71–1.44) 0.88 (0.63–1.24) 0.90 (0.64–1.26)
aStratified by age in months, adjusting for year, season, and state of residence. bStratified by age in months, adjusting for year, season, state of residence, BMI, hypertension, hyper­
cholesterolemia, diabetes, family history of MI, smoking (status and pack-years), physical activity, healthy diet, and alcohol consumption.Chronic PM, CVD, and mortality in the HPFS
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mortality; however, the study found an associ­
ation with traffic density, suggesting that traf­
fic­related pollution may be more   important 
in men.
Differences between our study findings and 
previously published results may stem from 
differences in the populations examined, pol­
lution measures, and covariates considered in 
analyses. For example, city­specific PM2.5 aver­
ages in the Harvard Six Cities Study ranged 
from 11.4 to 29.0 µg/m3 in the original time 
period (Dockery et al. 1993) and from 10.2 to 
22.0 µg/m3 in the extended period (Dockery 
et al. 1993; Laden et al. 2006), which includes 
our range of average estimated exposure from 
baseline (17.8 µg/m3) to the final year of fol­
low­up (12.5 µg/m3). However, the Harvard 
Six Cities Study population exhibited higher 
percentages of smokers, a lower level of edu­
cational attainment, and between 28 and 53% 
occupationally exposed to dust/fumes, factors 
that may increase susceptibility to ambient air 
pollution exposures. Metropolitan area PM2.5 
measures were used to estimate exposure in 
the American Cancer Society Study (Pope 
et al. 2002), which reported an average par­
ticipant exposure of 17.7 µg/m3, similar to our 
study average. As with the Harvard Six Cities 
Study (Dockery et al. 1993; Laden et al. 2006) 
and the American Cancer Society Study (Pope 
et al. 2002), pollution levels did not differ 
greatly between our study and the Medicare 
Cohort Air Pollution Study (Zeger et al. 
2008). Using a 6­year average exposure esti­
mated at the ZIP code level, the interquartile 
range of PM2.5 exposure (12.3–15.3 µg/m3 
for Eastern region) was lower than our base­
line interquartile range (15.6–19.9 µg/m3). 
Reported RRs in this study were higher than 
those in our study, with models adjusting for 
fewer and area level covariates: socioeconomic 
status and chronic obstructive pulmonary dis­
ease. The Medicare Cohort Study population 
was also of lower socioeconomic status than 
the health professionals; however, Zeger et al. 
(2008) reported that analyses stratified by the 
national median of socioeconomic status were 
similar. Results from the NCLS (Brunekreef 
et al. 2009) were more comparable with 
our findings, and similar to our study, they 
adjusted for a much larger number of potential 
confounders than previous studies. Full cohort 
analyses were adjusted for age, sex, smoking, 
area level income, and area. Case­cohort anal­
yses, which showed lower RRs, were adjusted 
for age, sex, weight/height squared, smoking, 
marital status, diet, alcohol use, education, 
occupation, and area­level income. In addi­
tion, pollution exposure methods included the 
use of updated residential addresses. We also 
note that although we have presented major 
findings in interquartile range change as well 
as 10­µg/m3 increments, some direct compari­
sons between previously published study find­
ings and ours are limited because of differences 
in the units used for incremental change.
Few studies of chronic air pollution expo­
sures have examined cerebrovascular outcomes. 
In the American Cancer Society Study, Pope 
and colleagues reported an increased risk of 
2% (95% CI, –5 to 10%) for cerebrovascular 
death associated with a 10­µg/m3 increase in 
fine particulate exposures, which falls between 
our risk estimates for incident ischemic and 
hemorrhagic strokes with an interquartile­
range change in average PM2.5 (4 µg/m3) 
(Pope et al. 2004). Among a national cohort 
of women (the Women’s Health Initiative), 
findings for first stroke associated with PM2.5 
exposures were stronger, with a reported HR 
of 1.28 (95% CI, 1.02–1.61) for a 10­µg/m3 
increase (Miller et al. 2007).
Although some studies have not found 
significant differences between men and 
women, others have reported estimated 
effects of greater magnitude for women 
(Brunekreef et al. 2009; Chen et al. 2005; 
Miller et al. 2007; Zeger et al. 2008). 
Although the Medicare Cohort Study did 
not find significant sex differences, the 
reported mortality risks in the eastern United 
States associated with a 10­µg/m3 increase 
in PM2.5 exposure were slightly higher for 
women (8.5%; 95% CI, 6.3–10.6%) than 
men (7.0%; 95% CI, 5.2–8.8%) (Zeger et al. 
2008). Risks for cardiovascular outcomes 
were much higher for the Women’s Health 
Initiative study, which showed HRs of 2.21 
(95% CI, 1.17–4.16) for fatal CHD (definite 
diagnosis) and 1.24 (95% CI, 1.09–1.41) 
for total CVD with a 10­µg/m3 change in 
PM2.5 (Miller et al. 2007). Average PM2.5 
exposure (13.5 µg/m3) and educational level 
were lower among this population than for 
our study of men, but they were comparable 
overall for many other health risks and behav­
iors. HRs were also stronger in the Nurses’ 
Health Study, which used the same exposure 
estimation methods and geographic area as 
the current study, although the women gen­
erally showed worse health indicators (e.g., 
less physically active, more current smokers) 
and lived in areas of lower socioeconomic 
status (Puett et al. 2008, 2009). The HRs 
for all­cause mortality were 1.26 (95% CI, 
1.02–1.54); 1.03 (95% CI, 0.89–1.18); 1.07 
(95% CI, 0.97–1.18) with a 10­µg/m3 change 
in PM2.5, PM10–2.5, and PM10, respectively, 
and 2.02 (95% CI, 1.07–3.78) for fatal CHD 
with a 10­µg/m3 change in PM2.5, in mod­
els adjusting for similar potential confound­
ers (Puett et al. 2009). HRs for nonfatal MI 
appear to be stronger in the current study 
of men (Nurses’ Health Study HR = 0.73; 
95% CI, 0.48–1.12 for a 10­µg/m3 change in 
PM2.5). The Adventist Health Study on the 
Health Effects of Smog (AHSMOG) cohort 
Table 4. HRs for all-cause mortality and fatal CHD associated with an interquartile-range (4 µg/m3) change 
in average 12-month PM2.5 exposure, stratified by MI family history and smoking status, respectively.a,b
Variable Cases Person-years HR (95% CI) LRT p-value
Family history of MI All-cause mortality
No 2,439 189,619 0.91 (0.85–0.98) < 0.01
Yes 374 30,933 1.08 (0.91–1.29)
Smoking status Fatal CHD
Never 195 86,571 1.28 (1.01–1.63) 0.04
Former 398 95,384 0.90 (0.77–1.06)
Current 47 13,550 1.40 (0.88–2.21)
aModeled stratifying by age in months, adjusting for state of residence, year, and season, smoking status, hypercho-
lesterolemia, diabetes, hypertension, BMI, diet, alcohol consumption, and physical activity. bResults presented for 
complete smoking data. 
Table 3. HRs (95% CIs) for associations of interquartile-range (4 µg/m3) changes in average predicted copollutant (PM2.5 and PM10–2.5 ) exposures, adjusting for 
covariates.
All-cause mortality Fatal CHD Nonfatal MI Total CVD Ischemic strokes Hemorrhagic strokes
(2,813 cases, (746 cases, (646 cases, (1,661 cases, (230 cases, (70 cases,
220,552 person-years) 220,562 person-years) 214,919 person-years) 212,649 person-years) 218,944 person-years) 220,292 person-years)
Basic modela
PM2.5 0.96 (0.89–1.04) 0.97 (0.83–1.13) 1.06 (0.90–1.25) 0.99 (0.90–1.10) 0.74 (0.56–0.96) 1.33 (0.86–2.06)
PM10–2.5 1.00 (0.94–1.06) 1.06 (0.94–1.20) 1.00 (0.88–1.14) 1.04 (0.96–1.13) 1.24 (0.99–1.54) 0.77 (0.52–1.15)
Full modelb
PM2.5 0.94 (0.87–1.02) 0.97 (0.83–1.13) 1.06 (0.90–1.25) 0.99 (0.90–1.10) 0.76 (0.58–0.99) 1.35 (0.87–2.09)
PM10–2.5 0.98 (0.92–1.05) 1.04 (0.92–1.17) 1.00 (0.87–1.14) 1.03 (0.95–1.12) 1.22 (0.98–1.52) 0.78 (0.53–1.16)
aStratified by age in months, adjusting for year, season, and state of residence. bStratified by age in months, adjusting for year, season, state of residence, BMI, hypertension, hyper­
cholesterolemia, diabetes, family history of MI, smoking (status and pack-years), physical activity, healthy diet, and alcohol consumption.Puett et al.
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study of men and women also reported stron­
ger estimated effects among women for fatal 
CHD with higher overall levels of PM10 and 
PM2.5 exposure than those in the current 
study (Chen et al. 2005). For a 10­µg/m3 
change in PM2.5, the RR for women was 1.42 
(95% CI, 1.06–1.90) and 0.90 (95% CI, 
0.76–1.05) for men. RRs associated with 
PM10 and PM10–2.5 were also higher than 
comparable risks for men; however, given the 
differences in exposure contrasts, results are 
not directly comparable. However, as for the 
Nurses and Health Professionals air pollu­
tion study comparisons, we cannot rule out 
the impact of education and lifestyle differ­
ences. Men in the AHSMOG study exhibited 
slightly higher levels of education and physical 
activity than the women.
Modification of air pollution–associated 
outcomes by sex is biologically plausible, given 
that some studies have shown greater fractions 
of deposition for inhaled particles among 
women (Bennett et al. 1996; Jaques and Kim 
2000; Kim and Hu 1998). As Dockery and 
Stone (2007) suggest, the evidence may also 
point to increased susceptibility to air pollu­
tion due to an underlying cardiac profile that 
is more common among women, given that 
sex differences in the studies described appear 
more consistent with respect to cardiovascular 
outcomes. Some studies have shown sex dif­
ferences in the cardiovascular pathways that 
air pollution may impact (Hoffmann et al. 
2009; Kublickiene and Luksha 2008; Noon 
et al. 2008; Sztajzel et al. 2008). However, the 
specific biological mechanisms through which 
PM air pollution affects all­cause mortality 
and cerebrovascular and CVD outcomes have 
not been fully elucidated. Proposed pathways 
include endothelial dysfunction, oxidative 
stress, and inflammation (Donaldson et al. 
2001; Pope et al. 2004; Pope and Dockery 
2006; Utell et al. 2002).
Our GIS­based temporal spatial smooth­
ing models of PM exposures resulted in esti­
mates that fell into the range of exposures 
reported by previous studies. As previously 
reported, our models showed high predictive 
accuracy and precision, with R2 ranging from 
0.62 to 0.77 (Yanosky et al. 2008, 2009). 
However, the possibility of residual con­
founding exists, because we did not include 
such environmental covariates as temperature. 
Given that the risk sets in the Cox model are 
updated monthly and we control for state 
and season in the model, the level of residual 
confounding is likely to be negligible. We 
also did not have information on behav­
ioral covariates, such as time spent outside 
or proportion of time spent at the address, 
which may lead to misclassification in the 
personal exposure estimate. Part of the differ­
ence between these results and those from the 
Nurses’ Health Study may be attributable to 
residential addresses being used for the nurses, 
whereas a mixture of occupational and resi­
dential addresses were available for the health 
professionals. However, results did not change 
for the men when the analysis was restricted 
to known residential addresses.
Findings from the current study may not 
be generalizable to other populations of men. 
Our study population represented a narrower 
range of socioeconomic status and fewer occu­
pational exposures to dust and fumes than 
the U.S. population as a whole. The Health 
Professionals Follow­Up Study consisted of 
health professionals with high levels of edu­
cational attainment, physical activity, never 
smokers, and low­risk diets. Therefore, they 
are likely to be much healthier than average. 
The death rate in the general population of 
U.S. men 65–69 years of age has been esti­
mated to be 2,125 deaths per 100,000 per­
son­years (Centers for Disease Control and 
Prevention 2007), whereas the rate of nonac­
cidental deaths in the Health Professionals 
Follow­up Study is 1,275 per 100,000 person­
years. Similarly, the incidence rate of CVD 
in this cohort (7.8 cases per 1,000 person­
years) (National Heart, Lung and Blood 
Institute 2006) is lower than that reported by 
the Framingham Heart Study (34.6 cases per 
1,000 person­years for men 65–74 years of 
age), a study more representative of the general 
population. However, rates could be somewhat 
more similar than those reported here because 
of our inability to make exact comparisons 
with our age strata and time period.
Findings have been somewhat inconsis­
tent regarding the impact of socioeconomic 
status on relationships between mortality 
(Bateson and Schwartz 2004; Krewski et al. 
2000; Pope et al. 2002), CVD, and air pol­
lution exposures; however, as Bateson and 
Schwartz (2004) suggest, inconsistencies may 
be attributable somewhat to differences in 
the geographic scale of these measures, with 
individual level measures showing higher 
risk for lower educational attainment. In the 
reanalysis of the American Cancer Society 
Study, men with education above high school 
showed RRs of all­cause mortality comparable 
with those found in our study (1.02; 95% CI, 
0.89–1.17) (Krewski et al. 2000). Healthier 
lifestyles may also reduce risks from air pollu­
tion, as demonstrated by increased risks of air 
pollution–associated cardiovascular outcomes 
among those with larger BMIs (Miller et al. 
2007; Puett et al. 2008, 2009). The impact 
of health behaviors in this population will be 
examined in detail in further work. In addi­
tion, the current study was restricted to the 
northeastern and midwestern United States, 
and the addresses used for assigning air pol­
lution exposure estimates were a mixture of 
work and residential addresses. Differences 
in findings from the current study compared 
with some other cohort studies may be par­
tially due to the differences in regional pollut­
ant mixtures, given that other cohort studies 
covered larger or dissimilar geographic areas 
of the United States (Dockery et al. 1993; 
Laden et al. 2006; Pope et al. 2002; Zeger 
et al. 2008). For example, Zeger et al. (2008) 
reported stronger risks for the central versus 
eastern regions of the United States. However, 
this does not account for the stronger risks 
found among Nurses’ Health Study cohort 
participants, as those studies were conducted 
in the same geographic region as the current 
study (Puett et al. 2008, 2009).
Conclusion
Overall, associations of chronic PM exposures 
with all­cause mortality or CVD outcomes 
were not evident in this population of male 
health professionals living in the northeast­
ern and midwestern United States. The lower 
HRs found in this study should be explored 
further to ascertain whether men with high 
socioeconomic status and healthy lifestyles 
are less susceptible to cardiovascular outcomes 
associated with long­term particle exposure.
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